Lv22
128 积分 2025-05-06 加入
Prognostic impact of intraductal carcinoma of the prostate and PTEN loss in metastatic castration-sensitive prostate cancer treated with androgen receptor pathway inhibitors
1小时前
求助中
The presence and clinical implication of intraductal carcinoma of prostate in metastatic castration resistant prostate cancer
1小时前
求助中
Clinical utility of intraductal carcinoma of the prostate in treatment selection for metastatic hormone‐sensitive prostate cancer
1小时前
已完结
Is there a role of PSMA-PET in focal therapy planning and follow-up?
1个月前
已完结
Targeting the tumour cell surface in advanced prostate cancer
1个月前
已完结
Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial
1个月前
已完结
Circulating Biomarkers Predictive of Treatment Response in Patients with Hormone-sensitive or Castration-resistant Metastatic Prostate Cancer: A Systematic Review
1个月前
已完结
Urinary exosomal FAM153C-RPL19 chimeric RNA as a diagnostic and prognostic biomarker for prostate cancer in Chinese patients
1个月前
已完结
Artificial intelligence: a new era in prostate cancer diagnosis and treatment
1个月前
已完结
基于微生物发酵的人参皂苷转化研究进展
6个月前
已采纳
皖公网安备34019202002308
